tirzepatide stronger than semaglutide vs UK: Mounjaro vs Wegovy Guide does tirzepatide work better than

Wegovy may not be suitable for everyone

These include: Prediabetes High blood pressure High cholesterol Atherosclerotic cardiovascular disease Osteoarthritis Fatty liver disease Polycystic ovary syndrome (PCOS) Obstructive sleep apnea Inflammatory states Research is ongoing to better understand the potential benefits of GLP-1 medications for heart disease, kidney disease and inflammation-related conditions

In the phase III STEP 6 trial conducted in Japan and South Korea, semaglutide 2.4 mg resulted in a mean percentage change in body weight from baseline to week 68 of -13.2% (standard error [SE] 0.5), compared with -2.1% (SE 0.8) achieved with placebo, corresponding to a between-group difference of -11.1% (95% confidence interval [CI], -12.9 to -9.2) using the treatment policy estimand

Hope all goes well and please let us know how you get on